$AVNU (Avenue Financial Holdings, Inc.)

$AVNU {{ '2016-06-23T08:44:19+0000' | timeago}} • Announcement

$AVNU shareholders will receive 0.36 shares of $PNFP stock and $2 in cash for every $AVNU share owned as of merger date. Assuming all outstanding $AVNU options are cashed out by merger date, $AVNU shareholders will own about 8.2% of the combined firm. Combined company is expected to have total assets of over $10.5Bil and total deposits of $8Bil.

$VVV {{ '2018-01-09T13:57:44+0000' | timeago}} • Announcement

$VVV, a producer of automotive lubricants, has appointed Brad Patrick as Chief People and Communications Officer. Patrick, who joins the company from Tempur Sealy International, will report to Valvoline's CEO Sam Mitchell. Previously, Patrick held key HR positions at Sara Lee, The Gillette, Delta Air Lines and Frito-Lay.

$CHCO {{ '2017-12-14T13:05:43+0000' | timeago}} • Announcement

$CHCO's BoD declared a quarterly dividend of 46 cents per common share. The dividend is payable on Jan. 31, 2018 to shareholders of record as of Jan. 15, 2018. The dividend represents a 4.5% increase from the 44 cents per share cash dividend paid in 4Q17.

$BIVV {{ '2017-12-11T20:56:54+0000' | timeago}} • Announcement

Biotechnology company $BIVV said results of the latest study conducted on its class monoclonal antibody BIVV009, indicated for the treatment of cold agglutinin disease,  achieved the primary and secondary endpoints. The endpoints included tolerability, pharmacokinetic profile supporting biweekly dosing, and classical complement pathway inhibition.

$BIVV {{ '2017-12-11T16:32:18+0000' | timeago}} • Announcement

$BIVV and Swedish Orphan Biovitrum AB said new data showed that individualized dosing with extended half-life therapy, Alprolix, every 14 or more days may be a potential option for people with severe hemophilia B who seek the benefits of protection from a prophylactic therapy with reduced treatment burden.

$AOBC {{ '2017-12-07T23:34:23+0000' | timeago}} • Announcement

$AOBC now sees 3Q18 net sales of $170-180MM generating a GAAP EPS of $0.01-0.04 and adjusted EPS of $0.07-0.10. For FY18, the firearm maker expects net sales of $650-675MM generating a GAAP EPS of $0.33-0.43 and adjusted EPS of $0.57-0.67.

$AOBC {{ '2017-12-07T23:31:45+0000' | timeago}} • Announcement

With wholesaler and retailer orders slumping, iconic Smith & Wesson firearm maker $AOBC saw quarterly net sales slump 36% to $148.4MM in 2Q18. Net income reduced to a measly $3.2MM or $0.06 per diluted share, about one-tenth f om last year's $32.5MM or $0.57 per diluted share.

$ABCB {{ '2017-12-07T12:48:38+0000' | timeago}} • Announcement

$ABCB said Edwin Hortman Jr. will be succeeded as CEO of Ameris Bank by Dennis Zember Jr., previously EVP, CFO and COO of the company and EVP and COO of Ameris Bank, effective as of Jan. 1, 2018. Nicole Stokes has been promoted to EVP and CFO of the company and Ameris Bank effective Jan. 1, 2018.

$DWDP {{ '2017-12-01T20:09:10+0000' | timeago}} • Announcement

Dow Chemical proclaimed that it had completed the sale of a part of its Dow AgroSciences' corn seed business in Brazil to China’s CITIC for $1.1Bil. Dow, a subsidiary of $DWDP, sold the seed business as part of the conditional regulatory approval from Brazil's Administrative Council for Economic Defense for its recently completed merger with DuPont.

$SFNC {{ '2017-11-30T13:42:17+0000' | timeago}} • Announcement

$SFNC has declared a regular quarterly cash dividend of $0.25 per share on its common stock. The dividend is payable on January 2, 2018, to shareholders of record on December 15, 2017.

$BIVV {{ '2017-11-27T16:50:11+0000' | timeago}} • Announcement

$BIVV said the FDA has approved updated labeling for ALPROLIX, the extended half-life therapy for the treatment of patients with hemophilia B. These updates are based on interim data from the Phase 3 B-YOND open-label extension trial and final data from the Phase 3 Kids B-LONG pediatric study.

$ABCB {{ '2017-11-17T16:07:27+0000' | timeago}} • Announcement

$ABCB agreed to buy $ACFC. Upon completion of the transaction, the combined company will have approximately $8.6Bil in assets, $6.9Bil in loans, $6.6Bil in deposits and a branching network across four states. The transaction is valued at about $145MM in the aggregate. The transaction is expected to close in 2Q18.

$BHF {{ '2017-11-16T17:28:01+0000' | timeago}} • Infographic

$BHF Brighthouse Financial, Inc. Earnings AlphaGraphic: Q3 2017 Highlights

$VVV {{ '2017-11-15T12:18:30+0000' | timeago}} • Announcement

$VVV has increased the quarterly cash dividend on the company’s common stock by more than 50%, from $0.049 to $0.0745 per share. The dividend will be payable on Dec. 15, 2017, to shareholders of record as of the close of business on Dec. 1, 2017.

$DWDP {{ '2017-11-03T17:45:17+0000' | timeago}} • Announcement

Amid investors pressure on realigning few operations in Agriculture, Specialty Products and Materials Science business units, $DWDP reported its first quarterly earnings after the Dow-DuPont merger. Net sales jumped 23% to $15.3Bil for the third quarter of 2017. GAAP EPS plunged 49% to $0.32, while pro forma adj. EPS rose 10% to $0.55.

$DWDP {{ '2017-11-02T15:21:30+0000' | timeago}} • Infographic

$DWDP DowDuPont Inc. Earnings AlphaGraphic: Q3 2017 Highlights

$LION {{ '2017-10-20T16:15:21+0000' | timeago}} • Announcement

$LION's BoD declared a quarterly cash dividend of $0.12 per share on its Common Stock. This dividend is payable on Nov. 14, 2017, to shareholders of record on Nov. 1, 2017.

$VVV {{ '2017-10-02T21:27:08+0000' | timeago}} • Announcement

$VVV has completed the acquisition of 56 Valvoline Instant Oil ChangeSM (VIOC) franchise service centers from Henley Bluewater LLC. Following the acquisition, the company has a network of 439 company-owned locations.

$SGMO {{ '2017-10-02T16:06:18+0000' | timeago}} • Announcement

$SGMO and $BIVV said the FDA has accepted the Investigational New Drug (IND) application for ST-400, a gene-edited cell therapy candidate for people with transfusion-dependent beta-thalassemia. $SGMO expects to open several clinical sites across the United States and begin enrolling patients in 1H18.

$SGMO {{ '2017-10-02T16:05:15+0000' | timeago}} • Announcement

$SGMO and $BIVV said the FDA has accepted the Investigational New Drug (IND) application for ST-400, a gene-edited cell therapy candidate for people with transfusion-dependent beta-thalassemia. This is as part of exclusive worldwide collaboration to develop and commercialize gene-edited cell therapies for beta-thalassemia and sickle cell disease.

$VVV {{ '2017-09-29T11:54:15+0000' | timeago}} • Announcement

Supplier of premium branded lubricants and automotive services $VVV said that William Wulfsohn, who served as the company's founding chairman during its initial year as a public company, will step down from his position as Chairman of the Board as of Sept. 30, 2017.

Recent Transcripts

AOBC (American Outdoor Brands Corporation)
Thursday, December 7 2017 - 10:00pm
DVMT (Dell Technologies Inc.)
Thursday, December 7 2017 - 1:00pm
HOME (At Home Group Inc.)
Wednesday, November 29 2017 - 9:30pm
VREX (Varex Imaging Corporation)
Thursday, November 9 2017 - 10:00pm
VVV (Valvoline Inc.)
Thursday, November 9 2017 - 2:00pm
BHF (Brighthouse Financial, Inc.)
Thursday, November 2 2017 - 4:00pm
DWDP (DowDuPont Inc.)
Thursday, November 2 2017 - 12:00pm
SBCF (Seacoast Banking Corp. of Florida)
Friday, October 27 2017 - 2:00pm
BIVV (Bioverativ Inc.)
Friday, October 27 2017 - 12:00pm
ITGR (Integer Holdings Corporation)
Thursday, October 26 2017 - 9:00pm
SSB (South State Corporation)
Tuesday, October 24 2017 - 2:00pm
SFNC (Simmons First National Corporation)
Monday, October 23 2017 - 2:30pm
ABCB (Ameris Bancorp)
Thursday, October 19 2017 - 2:00pm
RNST (Renasant Corp.)
Wednesday, October 18 2017 - 2:00pm
UBSH (Union Bankshares Corporation)
Wednesday, October 18 2017 - 1:00pm
AOBC (American Outdoor Brands Corporation)
Thursday, September 7 2017 - 9:00pm
DVMT (Dell Technologies Inc.)
Thursday, September 7 2017 - 12:00pm
HOME (At Home Group Inc.)
Tuesday, September 5 2017 - 8:30pm
VREX (Varex Imaging Corporation)
Thursday, August 3 2017 - 9:00pm
BIVV (Bioverativ Inc.)
Thursday, August 3 2017 - 12:00pm

AlphaGraphics you may like